CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)
Clinical trial NCT01848990 · COMPLETED
Trial details
- NCT number
- NCT01848990
- Sponsor
- Halozyme Therapeutics
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2014-02-01
- Enrollment
- 456
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.